Christobel Selecky
Director at ImmunityBio, Inc. (IBRX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 6SEC | IBRXImmunityBio, Inc. | Sell Plan | 159,478 | $9.02 | $1.4M | +16.5% |
| Jul 1SEC | IBRXImmunityBio, Inc. | Sell Plan | 95,722 | $9.01 | $862K | +16.6% |
| Jul 1SEC | IBRXImmunityBio, Inc. | Sell Plan | 1,000 | $9.00 | $9K | +16.8% |
| Feb 24SEC | IBRXImmunityBio, Inc. | Sell Plan | 25,000 | $10.00 | $250K | +5.1% |
| Jan 21SEC | IBRXImmunityBio, Inc. | Sell Plan | 50,000 | $5.00 | $250K | +110.2% |
| Jan 21SEC | IBRXImmunityBio, Inc. | Sell Plan | 25,000 | $7.51 | $188K | +39.9% |
- Sell
Director Christobel Selecky sold $1.4M of IBRX at $9.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christobel Selecky sold $862K of IBRX at $9.01 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christobel Selecky sold $9K of IBRX at $9.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christobel Selecky sold $250K of IBRX at $10.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christobel Selecky sold $250K of IBRX at $5.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christobel Selecky sold $188K of IBRX at $7.51 — pre-scheduled 10b5-1 plan sale.